About TREATT
TREATT is a publicly listed company based in United Kingdom founded in 1886. Supplier of flavour fragrance Ingredients for food industries. The company has 379 employees. Its chief executive, as recorded, is Daemmon Reeve. Its website treatt.com draws about 12 thousand monthly visits. TREATT offers products and services including Citrus Extracts, Coffee Extracts, Tea Extracts, and Herbs and Spices Blends. Its focus areas include Consumer Goods, Beauty & Personal Care Products, Fragrances and Multi Category. Its legal entity is TREATT PLC.
Company details
TREATT supplier of flavour fragrance ingredients for food industries, focusing on producing consumer products, beauty personal care products, fragrances, and multi category. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.
- Headquarters United Kingdom
- Employees 379
- Stage Public
- SectorsConsumer
- Email••••••••
- Phone•••• ••••
- Website treatt.com
- Social LinkedIn X YouTube
- Legal Name Treatt Plc
- Annual Revenue$178.08 M (USD)-11.8as on Sep 30, 2025
- Net Profit$6.8 M (USD)-63.46as on Sep 30, 2025
- EBITDA$21.01 M (USD)-37.69as on Sep 30, 2025
- Latest Funding Round$28.8M (USD), Post-IPO
Nov 2017
- InvestorsInnovate UK
& 1 more
- Employee Count379
Products & Services of TREATT
TREATT offers a comprehensive portfolio of products and services, including Citrus Extracts, Coffee Extracts, Tea Extracts, and Herbs and Spices Blends.
Natural extracts from citrus for beverages and flavor enhancement.
Extracts for re-defining brewed coffee experiences.
Authentic extracts designed for product differentiation.
Quality-driven blends for natural ingredient applications.
Apps and channels of TREATT
its YouTube channel TreattWorld has 76 subscribers and 23 videos.
Videos from TREATT
The most watched videos on TREATT's YouTube channel, TreattWorld (76 subscribers). Click a video to play it here.
More on TreattWorld.
Funding Insights of TREATT
- Total Rounds 2
- Last Round Post-IPO — $28.8M
- First Round $71,333
(Jan 2016)
- Investors Count 1
All 2 funding rounds of TREATT with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2017 | $28.8M | Post-IPO | – | – | – |
| Jan 2016 | $71,333 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in TREATT
TREATT has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Innovate UK.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| innovateuk.gov.uk |
Investor details for TREATT
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of TREATT
36 people are tracked at TREATT (6 in leadership, 4 in board & advisors, 26 in team); the tracked headcount is 379.
| Name | Role | Group |
|---|---|---|
Daemmon Reeve | CEO | Leadership |
Rebecca Wood | Head Of Customer Service & Commercial Performance | Leadership |
Babette Norman | Eu/uk Operations Director | Leadership |
Ryan Govender | Group CFO & MD Europe | Leadership |
Mark Rowland | Head Of IT Development | Leadership |
Doug South | General Manager Of North America | Leadership |
Yetunde Hofmann | Director | Board & advisors |
Tim Jones | Chairman | Board & advisors |
Richard Illek | Director | Board & advisors |
David Johnston | Director | Board & advisors |
Tracey Smith | Global Analytical Scences Manager | Team |
Christopher Lingle | Senior Product Development Scientist | Team |
Natalie Barton | Import/export Logistics Manager | Team |
Joe Carter | Innovation Scientist (level 2) | Team |
Joshua Moore | Process Development Scientist | Team |
Thomas Filarowski McHem Mrsc | Process Development Scientist | Team |
Mike Koziel | Plant Manager | Team |
Barnaby Jones | European Demand And Planning Manager | Team |
Richard Scargill | Group Financial Controller | Team |
Marc G. | IT Development Team Leader | Team |
16 more people are available in the full profile.
Complete people profiles for TREATT
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of TREATT
TREATT is a publicly listed company on the LSE with ticker symbol TET in UK, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date10 May 1989
- Listed onLSE: TET
- Listed entityTreatt plc
- Exchange sectorProcess industries
- ISINGB00BKS7YK08
- Share price300.00 GBX (+0.33% on the day) · 2026-05-11
- Market capitalisation176,539,127.00 GBX
- Price to earnings41.6
- EPS (diluted, trailing year)0.07 GBX
- Dividend yield1.87%
- Volume (last session)90,378
- Analyst consensusNeutral
Financials of TREATT
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 132.5M GBP | 5.1M GBP | 15.6M GBP |
| 2024 | 153.1M GBP | 14.4M GBP | 25.6M GBP |
| 2023 | 147.4M GBP | 10.9M GBP | 23.5M GBP |
| 2022 | 140.2M GBP | 13.3M GBP | 18.2M GBP |
| 2021 | 124.3M GBP | 15.2M GBP | 23.4M GBP |
Detailed financial statements for TREATT
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of TREATT
4 dated milestones of TREATT across 131 years, from founding to its latest funding, stage changes and deals.
- Founded TREATT is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $71K.
- Funding Latest funding round, Post-IPO, of $28.8M.
Web traffic of TREATT
The website of TREATT (treatt.com) receives about 12.1K visits a month.
- Monthly visits12.1K
▲ 39.5% vs previous month
Websites whose visitors overlap most with TREATT. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| fragrance-oils.com | 100% | 4K | #4,387,907 | View details | |
| alphaaromatics.com | 86% | 71.2K | #523,038 | View details | |
| cirs-group.com | 86% | 134.6K | #355,443 | View details | |
jcbuck.co.uk | jcbuck.co.uk | 28% | #4,550,988 | – | |
thefragrancefoundry.co.uk | thefragrancefoundry.co.uk | 27% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 9 similar websites and full traffic analytics for TREATT
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 9 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Treatt
Complete news archive for TREATT
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about TREATT
TREATT was founded in 1886 and raised its 1st funding round 130 years after it was founded.
TREATT is headquartered in United Kingdom.
Daemmon Reeve is the CEO of TREATT, as recorded in our data.
TREATT has 379 employees.
Annual revenue of TREATT is $178.08M as on Sep 30, 2025.
TREATT supplier of flavour fragrance ingredients for food industries, focusing on producing consumer products, beauty personal care products, fragrances, and multi category. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.
TREATT offers Citrus Extracts, Coffee Extracts, Tea Extracts, and Herbs and Spices Blends.
Yes, TREATT is publicly traded on LSE under the ticker symbol TET.
TREATT has 1 investor. Key investors include Innovate UK.
TREATT operates through Treatt Plc.